A novel strategy to improve inclusion criteria, assess target engagement and determine efficacy in alpha-synucleinopathy treatment trials (5464)
Year: 2020
Type: article
Source: Neurology
Institution: Beth Israel Deaconess Medical Center
Language: English
Subfield: Neurology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3194497245
